GLP1R and angiosarcoma: We recently managed an obese woman who presented a very aggressive angiosarcoma of the abdominal wall in the context of repeated liraglutide subcutaneous injections, a glucagon-like peptid-1 receptor agonist, effective for weight management and glycemic control in type 2 diabetes [15].